J. Lyle Bootman

Drug-related morbidity and mortality. A cost-of-illness model.

Jeffrey Johnson, J. Lyle Bootman · PubMed · 1995 · 361 citations

The Health Care Cost of Drug-Related Morbidity and Mortality in Nursing Facilities

J. Lyle Bootman · Archives of Internal Medicine · 1997 · 263 citations

Nursing Facilities, Pharmacotherapy, Consultant Pharmacists +20

Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis

J. Lyle Bootman, Albert I. Wertheimer, Darwin E. Zaske et al. · Journal of Pharmaceutical Sciences · 1979 · 96 citations

Antibiotics, Patient Safety, Sepsis +6

Time Preference for Health Gains Versus Health Losses

Linda MacKeigan, Lon N. Larson, JoLaine R. Draugalis et al. · PharmacoEconomics · 1993 · 69 citations

Health Effect, Preventive Medicine, Health Economics +6

Cost-benefit and cost-effectiveness: Methodologies for evaluating innovative pharmaceutical services

William F. McGhan, Clayton R. Rowland, J. Lyle Bootman · American Journal of Health-System Pharmacy · 1978 · 40 citations

Innovation Evaluation, Pharmacotherapy, Cost-effectiveness Analysis Techniques +19